P3 Health Partners Inc. (PIII)

P3 Health Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-137.63	-135.85	-57.77	-270.13	-204.34	-31.41
Depreciation & Amortization	85.57	86.06	86.68	87.29	8.72	0.8
Other Amortization	0.09	0.09	0.47	-	1.8	0.23
Loss (Gain) From Sale of Assets	-5.21	-5.21	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	1,315	-	-
Stock-Based Compensation	6.11	5.75	5.98	19.4	8.34	0.45
Other Operating Activities	-152.4	-148.94	-141.68	-1,312	43.23	-20.54
Change in Accounts Receivable	9	-3.76	-42	-27.18	0.45	-27.37
Change in Accounts Payable	-0.96	-8.1	15.99	6.08	41.96	8.1
Change in Other Net Operating Assets	71.86	99.84	56.3	55.92	33.38	45.15
Operating Cash Flow	-123.56	-110.13	-76.03	-126.02	-66.47	-24.6
Capital Expenditures	-	-	-1.83	-2.23	-3.41	-2.93
Sale of Property, Plant & Equipment	14.53	14.53	-	-	-	-
Cash Acquisitions	-	-	-	-5.5	-52.87	-0.13
Other Investing Activities	-	-	-	-	0.21	-0.11
Investing Cash Flow	14.53	14.53	-1.83	-7.73	-56.07	-3.17
Short-Term Debt Issued	-	1.87	-	-	3.73	-
Long-Term Debt Issued	-	88.06	14.1	15	25	36.43
Total Debt Issued	109.19	89.93	14.1	15	28.73	36.43
Long-Term Debt Repaid	-	-30.97	-	-3.63	-0.19	-1.49
Net Debt Issued (Repaid)	78.31	58.96	14.1	11.38	28.53	34.94
Issuance of Common Stock	40.5	40.53	86.6	-	195.31	-
Repurchase of Common Stock	-0.03	-0.1	-0.02	-	-	-0.18
Other Financing Activities	-0.75	-0.61	-0.35	-	-0.38	-
Financing Cash Flow	118.03	98.77	100.33	11.38	223.47	34.76
Net Cash Flow	8.99	3.17	22.48	-122.38	100.93	7
Free Cash Flow	-123.56	-110.13	-77.86	-128.25	-69.88	-27.52
Free Cash Flow Margin	-8.32%	-7.34%	-6.15%	-12.22%	-10.96%	-5.61%
Free Cash Flow Per Share	-39.55	-37.46	-13.21	-154.23	-84.03	-20.90
Cash Interest Paid	14.19	14.19	5.81	5.71	4.14	0.69
Cash Income Tax Paid	5.48	5.48	0.57	-	-	-
Levered Free Cash Flow	-7.21	-4.59	-13.58	-33.15	-8.76	-18.74
Unlevered Free Cash Flow	9.35	9.18	-4.06	-26.02	-3.88	-17.38
Change in Working Capital	79.91	87.98	30.3	34.82	75.78	25.89

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q